Mannitol Injection, Solution
Product Images NDC 51662-1468

This is a list of possible side effects and complications associated with a medication or treatment. These include urinary and renal disorders such as increased urination and urinary retention, neurotoxicity leading to headache, convulsions and dizziness, cardiac disorders such as tachycardia and chest pain, as well as respiratory and gastrointestinal disorders. Vascular disorders such as thrombophlebitis and hypotension are also listed, as well as musculoskeletal disorders such as arm pain, and skin disorders like urticaria and necrosis. Injection site reactions are also mentioned, as are general symptoms such as fever, chills, thirst and edema.*

This text appears to be a table showing concentration levels in terms of percentage and milliosmoles per liter. It also includes a calculation column. The last row shows a range of values for an unknown parameter between 4.5 to 7.0. Unfortunately, the context for this information is missing, so it is unclear what these values represent.*

This is a description of a medication Concentration with a National Drug Code (NDC) of 0409-4031-01. The cost is 12.5 cents for a 50ml dose. It comes in a tray of 25 individual single-dose fliptop vials, with each vial containing a concentration of 250mg/mL.*

This is a 50 mL single-dose fliptop vial containing 25% Mannitol for intravenous use only. The vial has a code number (01) 00351662146811 and a manufacturing date of (17) 201101. The vial is produced by Hospira, Inc. located in Lake Forest, IL, USA. The vial is packaged with a warning insert regarding contraindication in severe renal impairment. The vial is distributed by HF Acquisition Co. located in Mukilteo, WA. RX Only.*

This is a medication in a single-dose Fliptop vial packaging with a 50 mL capacity, with the Rxonly label and NDC code 0409-4031-16. The drug contains 25% Mannitol ket and is in an injection form, specifically USP Couton, Impect_careull _crystls. It's advisable to warm it to 80°C and agitate it before administering through intravenous use only. Usual dosage applies, and the user should read the sterile insert, which describes the product as sterile and nonpyrogenic. It should be stored at 20°to 25°C (68°to 7) and the user should also read the warning in the insert regarding contraindication in severe renal impairment. The drug comes from Hospira, Inc in Lake Forest, IL 60045 USA, and its name is Rkzaine Hospira.*

This is a 50mL single-dose fliptop vial available only through prescription. Each milliliter of the solution contains 250mg of Mannitol along with the presence of sodium bicarbonate and/or HCl for pH adjustment. The pH value ranges between 5.0-7.0. The instructions suggest inspecting the solution carefully and if crystals are present, warm it to 80°C and agitate gently to dissolve, and then administer it intravenously at a temperature between 30°C to 37°C. A sterile filter must be used, and the dosage should be as per the insert. There is a warning issued regarding the use of the vial for severe renal impairment, and the vial should be stored at room temperature. However, if it is not clear or seal-intact, it should not be used. This product is distributed by Hospira Inc, located in Lake Forest, IL, USA. Unfortunately, there are a few DMMWYY{E© characters that are not readable.*

This appears to be a label for a medication called "MANNITOL" in an injection form with a concentration of 25%. The volume of the injection is 125 9/50 mL, which correlates to 250 mg/ml. The manufacturer is likely "Fo renos e Oy".*

This is a description of a single dose Fliptop Vial containing 25% MANNITOL injection, USP, manufactured by Hospira Inc, Lake Forest, Illinois, USA with 12.5g/50ml (250mg/mL) concentration. It is for intravenous use only and should be inspected carefully. It has a warning regarding contraindication in severe renal impairment. The vial also contains sodium bicarbonate and/or O for pH adjustment. It is sterile, non-pyrogenic, and should be used only if the seal is intact. The usual dosage is not available, and it should be administered through a series filter. It should be stored at 20 to 25°C (68 to 77°F) and used only in clear conditions. Not available is the actual content in the last line which seems to be poorly d.*